|
Volumn 1, Issue 4, 1999, Pages 371-374
|
Transdermal nicotine patches do not cause clinically significant gastroesophageal reflux or esophageal motor disorders
a,b a,b a,b a,b a,b a,b |
Author keywords
[No Author keywords available]
|
Indexed keywords
GANGLION STIMULATING AGENT;
NICOTINE;
ADULT;
ARTICLE;
CHEMICALLY INDUCED DISORDER;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
DYSPEPSIA;
GASTROESOPHAGEAL REFLUX;
GASTROINTESTINAL MOTILITY;
HEARTBURN;
HUMAN;
INTRADERMAL DRUG ADMINISTRATION;
RANDOMIZED CONTROLLED TRIAL;
SMOKING CESSATION;
ADMINISTRATION, CUTANEOUS;
ADULT;
DOUBLE-BLIND METHOD;
DYSPEPSIA;
GANGLIONIC STIMULANTS;
GASTROESOPHAGEAL REFLUX;
GASTROINTESTINAL MOTILITY;
HEARTBURN;
HUMANS;
NICOTINE;
SMOKING CESSATION;
|
EID: 0033288423
PISSN: 14622203
EISSN: None
Source Type: Journal
DOI: 10.1080/14622299050011511 Document Type: Article |
Times cited : (6)
|
References (11)
|